MADISON -- The interface between molecular biology, medical applications, law, religion and ethics will be the focus of the sixth annual international Bioethics Forum, hosted by Promega Corp.'s BioPharmaceutical Technology Center Institute (BTCI) in Fitchburg, Wis.
The title of this year's conference, to be held on Thursday and Friday, April 19-20, is "From Therapy to Enhancement." Featuring a series of keynote speakers and discussion sessions, the annual forum is designed to provide the public with access to accurate scientific information and a venue for discussing related social and ethical issues.
Confirmed keynote speakers, in order of presentation, include:
Gabriela Cezar, assistant professor, animal sciences, UW-Madison: Developing Therapeutics: From Research to Market
Andrew J. Imparato, president and CEO, American Association of People with Disabilities: Making the World Safe for Disability
Erik Parens, Associate for Philosophical Studies, The Hastings Center: Understanding the Enhancement Debate
Joe Palca, science correspondent, National Public Radio: How Do You Communicate Complexity and Uncertainty in 3 Minutes?
Maxwell Mehlman, Arthur E. Petersilge Professor of Law and director, Law-Medicine Center, Case Western Reserve University School of Law: The Social Control of Biomedical Enhancement
R. Alta Charo, Warren P. Knowles Professor of Law & Bioethics, UW-Madison: Fear and the First Amendment: Scientific Freedom, Social Disruption and the Political Expression
In addition to the keynote presentations, several discussion sessions will be held, including Student Voices; Prenatal Genetic Diagnosis: Links with the Enhancement Discussion; Novel Stem Cell Therapies: From Research to Clinic; Reflections from Diverse Faith Perspectives; How Do We Conduct Research Related to Enhancement?; Enhancement in the World of Sports.
The Bioethics Forum will take place a
'"/>
Contact: R. Alta Charo
racharo@wisc.edu
608-262-5015
University of Wisconsin-Madison
22-Mar-2007